Questioning the Role of a Neutropenic Diet following Hematopoetic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 9, 2012, Pages 1385-1390

  Trifilio, Steven ^a   Helenowski, Irene ^a   Giel, Meghan ^a   Gobel, Barbara ^a   Pi, Judy ^a   Greenberg, Deborah ^a   Mehta, Jayesh ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Antibiotics; Infection; Nutrition

Indexed keywords

ADULT; AGED; ARTICLE; BACILLUS; CANDIDIASIS; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CORYNEBACTERIUM INFECTION; DIARRHEA; DIET; DIETARY INTAKE; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI INFECTION; FEMALE; GEMELLA; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HISTOPLASMOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MUCORMYCOSIS; MYCOBACTERIOSIS; NEUTROPENIA; NEUTROPENIC DIET; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SACCHAROMYCES; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS VIRIDANS INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DIET; FEMALE; GASTROINTESTINAL TRACT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPENIA; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84865186541     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.02.015     Document Type: Article

References (20)

1. Tomblyn M., Chiller T., Einsele H., et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 2009, 44. 453-451.
2. Mukherjee A., Speh D., Dyck E., et al. Preharvest evaluation of coliforms, Escherichia coli, Salmonella, and Escherichia coli O157:H7 in organic and conventional produce grown by Minnesota farmers. J Food Prot 2004, 67:894-900.
3. Johnston L.M., Jaykus l, Moll D., et al. A field study of the microbiolobical quality of fresh produce. J Food Prot 2005, 68:1840-1847.
4. Jones J.M., Wilson R., Bealmear P. Mortality and gross pathology of secondary disease in germ-free mouse radiation chimeras. Radiat Res 1971, 45:577-588.
5. Hamilton-Miller J.M., Shah S. Identity and antibiotic susceptibility of enterobacterial flora of salad vegetables. Int J Antimicrob Agents 2001, 18:81-83.
6. Smith L.H., Besser S.G. Dietary restrictions for patients with neutropenia: a survey of institutional practices. Oncol Nurs Forum 2000, 27:515-520.
7. Gardner A., Mattiuzzi G., Faderl S., et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 2008, 26:5684-5688.
8. van Tiel F., Harbers M.M., Terporten P.H., et al. Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Ann Oncol 2007, 18:1080-1084.
9. DeMille D., Deming P., Lupinacci P., et al. The effect of the neutropenic diet in the outpatient setting: a pilot study. Oncol Nurs Forum 2006, 33:337-343.
10. Sonis S.T., Oster G., Fuchs H., et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001, 19:2201-2205.
11. Stecher B., Hardt W.D. The role of microbiota in infectious disease. Trends Microbiol 2008, 16:107-114.
12. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
13. Ubeda C., Taur Y., Jenq R.R., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
14. van Vliet M.J., Tissing W.J., Dun C.A., et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 2009, 49:262-270.
15. de la Cochetière M.F., Durand T., Lalande V., et al. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol 2008, 56:1143-1238.
16. Trifilio S., Pi J., Mehta J. Clostridium difficile-associated disease in hematapoetic stem cell transplantation recipients. [abstract]. Biol Blood Marrow Transplant 2009, 16(Suppl):S257-S258.
17. Viswanathan V.K., Mallozzi M.J., Vedantam G. Clostridium difficile infection: an overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes 2010, 1:234-242.
18. Vidal M., Forestier C., Charbonnel N., et al. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol 2010, 48:2595-2598.
19. Bossaer J.B., Hall P.D., Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2010, 19:231-237.
20. August D.A., Huhmann M.B. ASPEN clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enteral Nutr 2009, 33:472-500.